Molina Healthcare (NYSE:MOH) shares dropped more than 9% in premarket trading on Thursday after the health insurer issued a full-year revenue outlook that disappointed investors, despite reporting second-quarter earnings ahead of market expectations.
While profitability exceeded forecasts, concerns over slowing revenue growth and ongoing Medicaid headwinds weighed heavily on market sentiment.
Earnings beat fails to offset revenue concerns
Molina Healthcare reported adjusted earnings of $1.51 per share for the second quarter, ahead of analysts’ expectations of approximately $1.39 to $1.40.
Quarterly revenue reached approximately $10.87 billion, broadly matching market estimates.
However, the company maintained its full-year 2026 revenue forecast at around $42 billion, well below analysts’ consensus estimate of approximately $44.28 billion, prompting investors to reassess the company’s growth outlook.
Medicaid pressures remain a key challenge
Investors also focused on comments ahead of the company’s earnings call, where Chief Executive Joseph Zubretsky described 2026 as the “trough year” for Medicaid pretax margins.
Although Molina increased its full-year adjusted earnings guidance to at least $5.25 per share from its previous outlook of $5.00, the improved profit forecast failed to ease concerns about slowing revenue growth.
The company also continues to face pressure from weaker Marketplace enrolment and higher start-up costs associated with its Florida CMS Medicaid contract.
Membership declines continue
Molina ended the quarter with approximately 4.9 million members, down from around 5.0 million in the previous quarter, reflecting continued pressure on enrolment across parts of its business.
The decline reinforced investor concerns over the pace of membership growth at a time when Medicaid programmes continue to face regulatory and funding challenges.
Investors remain cautious on sector outlook
The broader equity market also traded lower, adding to pressure on healthcare stocks.
Analyst opinion ahead of the earnings release had been mixed. While several firms raised their price targets during July, others adopted a more cautious stance amid rising medical costs and continued declines in Medicaid enrolment.
Despite delivering stronger-than-expected earnings, Molina Healthcare’s weaker revenue guidance and ongoing operational challenges overshadowed the quarterly results, sending the stock sharply lower in premarket trading.
Molina Healthcare stock price
